Vasopressin-related Trial NCT05757557 Marked Completed as of Oct 23, 2026

On October 23, 2026, the clinical trial registry listed an update for the study titled "Perioperative Nitric Oxide Prevents Acute Kidney Injury in Cardiac Surgery Patients With Chronic Kidney Disease." The trial, registered as NCT05757557, is classified as Phase 1/Phase 2. Its current status is recorded as completed. Vasopressin is an approved compound referenced in connection with this trial record. The study examined perioperative use of nitric oxide in cardiac surgery patients who also have chronic kidney disease, with a focus on acute kidney injury prevention. No results or outcome data were included in this update. The registry entry confirms only the completion status and the associated dates, phase, and title as provided. No efficacy, safety, or comparative findings are stated in this record. Readers should not interpret the completed status as an indication of trial results or conclusions. Further details, including any posted results, would need to be confirmed through the official registry listing. This brief reflects only the information contained in the trial update as of the stated date. For additional background on vasopressin, its approved status, and general context, readers can consult the compound overview.